Ashwagandha and Stress

Why this comes up at all

Ashwagandha, Withania somnifera, is a plant used in Ayurvedic medicine for a very long time, and it is currently one of the best-selling supplements in the stress category.

It gets described as an adaptogen, a term meaning a substance that helps the body resist stressors non-specifically. That word carries less precision than it implies and I would not lean on it as an explanation.

What makes ashwagandha genuinely worth a brief is not the tradition or the terminology. It is that unlike most herbal supplements, it has accumulated a substantial body of randomized controlled trials, enough for multiple meta-analyses.

That puts it in a different evidence category from most of what sits beside it on the shelf, and it means the interesting question is not whether anything has been shown but what exactly, and how well.

What the human evidence actually shows

The most recent synthesis is a 2026 systematic review and dose-response meta-analysis in Complementary Therapies in Medicine, searching PubMed, Scopus and Web of Science, pre-registered on PROSPERO, and including 22 randomized controlled trials.

It found significant improvements in stress, in depression and in anxiety. It also found both a significant linear and a significant non-linear association between ashwagandha dose and stress levels, which is a genuine dose-response relationship rather than a flat effect.

An earlier 2022 meta-analysis in Phytotherapy Research asked a narrower version of the same question about anxiety and stress management.

Now I want to be straight with you about something in the 2026 numbers, because it is the kind of detail that separates an honest brief from a marketing page.

The reported effect sizes are extremely large. Standardised mean differences of around minus 5.88 for stress, minus 5.68 for depression and minus 6.87 for anxiety are far outside the range typical of psychological or pharmacological interventions, where an SMD of 0.8 is conventionally described as large.

Effect sizes of that magnitude usually indicate substantial heterogeneity between studies, small trials, or measurement scales that inflate the standardised difference, rather than an intervention several times more powerful than established treatments.

The authors were appropriately measured about this themselves, concluding that ashwagandha holds promising potential while stating that well-designed high-quality trials are still needed to address existing heterogeneity and to establish the most effective dosages and intervention durations.

So the honest read: a consistent direction across 22 randomized trials is meaningful and is more than most supplements have. The magnitude reported should be held loosely.

What this means in practice

The practical value here is that the direction is consistent across a real number of randomized trials, which is a reasonable basis for trying something with a good safety record.

It is not a reasonable basis for expecting a several-fold improvement in how you feel, and I would rather set that expectation now than have you conclude the supplement failed.

The dose-response finding is genuinely useful, since it suggests dose matters rather than any amount doing the same thing. Trials in this literature commonly use standardised root extracts, and the extract type and standardisation vary between products in ways the label does not always make clear.

There is also a framing point worth making. If the stress in question comes from a life that is genuinely too full, a supplement is working against a cause it cannot touch. That is not an argument against taking it, it is an argument for not letting it substitute for the harder conversation.

And if exhaustion is the dominant symptom rather than stress, it is worth knowing that a 2016 systematic review analysing 58 studies of cortisol testing found no substantiation for adrenal fatigue as a condition. The productive questions there are thyroid, iron, blood sugar and sleep, and those are measurable.

The honest hedge

I am not a doctor and I am not diagnosing anyone, and there are specific safety points here that are not decorative.

Ashwagandha has been associated with cases of liver injury. These are uncommon relative to how widely it is used, and they are documented, which makes it worth knowing rather than worth panicking about. Stop and see a doctor for yellowing of the skin or eyes, dark urine, persistent nausea or right-sided abdominal pain.

It can affect thyroid hormone levels, which matters in two directions: it may interfere with thyroid results, and it may interact with thyroid medication. If you have a thyroid condition, that belongs with your prescriber first.

It is generally avoided in pregnancy. And because it may have immunomodulating effects, anyone with an autoimmune condition or taking immunosuppressants should raise it with their prescriber rather than assume.

Sedative interactions are worth mentioning too if you take anything for sleep or anxiety.

Finally, and I would say this regardless of the evidence quality: if anxiety is significantly affecting your daily life, that deserves proper care rather than a supplement. In the US you can call or text 988 for the Suicide and Crisis Lifeline, any hour.

What to do with this

Read the meta-analysis as direction rather than magnitude. Consistent across 22 randomized trials is the useful finding. The reported effect sizes are implausibly large and the authors themselves flagged heterogeneity.

Check the extract and standardisation on the label. Trials use standardised root extracts, and products vary in ways the front of the bottle does not explain. The dose-response finding means this is not a detail to skip.

Raise it with your prescriber if you have a thyroid condition. It can affect thyroid hormones and interact with thyroid medication, which makes this a genuine conversation rather than a formality.

Know the liver warning signs before you start. Yellowing skin or eyes, dark urine, persistent nausea, right-sided abdominal pain. Stop and see a doctor.

Do not use it to paper over a life that is too full. A supplement cannot reach the cause, and treating it as though it can is how the actual problem gets postponed.

If exhaustion is the main symptom, test rather than supplement. A thyroid panel, ferritin with hs-CRP and fasting insulin answer more, from one draw.

Where the paid report goes further

This page covers what the published evidence says in general. It cannot tell you what it means for you, because it does not know your medications, your labs, your history, or your dose.

A paid research report does that work. Jess builds it around your actual situation, walks the citations, and writes what the evidence supports for someone in your position. The brief is the shorter version. The deep dive is the one where every citation is read and the reasoning is laid out end to end, and Jess reviews every deep dive personally before it goes out.

Neither is medical advice, and neither replaces your prescriber. What they replace is the evening you would otherwise spend trying to work out which of forty search results is telling you the truth.